Washington [US], November 28 (ANI): A common medicine that treats reflux, heartburn as well as ulcers that can hinder the effectiveness of lung cancer immunotherapy medicines, suggests new research by the Flinders University.
Adelaide [Australia], November 26 (ANI): According to a new research by the Flinders University, a common medicine that treats reflux, heartburn as well as ulcers can hinder the effectiveness of lung cancer immunotherapy medicines.
\
\
\
\
